-
-
-
-
-
-
-
Amarin Corp. (AMRN) Announces JAMA Publication Highlights VASCEPA Cardiovascular Risk Reduction Extends to Cost Effectiveness at Patient Level
-
-
-
-
-
-
-
Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/16: (HTZ) (GTT) (NAV) Higher; (TACO) (MRTN) (JBHT) Lower (more...)
-
-
-
-
-
-
-
VASCEPA® Approved in Canada to Reduce the Risk of Cardiovascular Events
-
-
-
-
-
-
-
Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
-
-
-
-
-
-
-
Amarin Announces $400,000,000 Public Offering of American Depositary Shares
-
-
-
-
-
-
-
UPDATE: Amarin Corp. (AMRN) Has ~5X Upside - Citi
-
924,271 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All